ATE531426T1 - Verwendung von alpha-lactalbumin zur regulierung von glykämie - Google Patents

Verwendung von alpha-lactalbumin zur regulierung von glykämie

Info

Publication number
ATE531426T1
ATE531426T1 AT07731348T AT07731348T ATE531426T1 AT E531426 T1 ATE531426 T1 AT E531426T1 AT 07731348 T AT07731348 T AT 07731348T AT 07731348 T AT07731348 T AT 07731348T AT E531426 T1 ATE531426 T1 AT E531426T1
Authority
AT
Austria
Prior art keywords
lactalbumin
alpha
glycemia
regulate
regulate glycemia
Prior art date
Application number
AT07731348T
Other languages
English (en)
Inventor
Daniel Tome
Jean-Francois Huneau
Takashi Mikogami
Benoit Laplaize
Original Assignee
Cie Laitiere Europeenne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cie Laitiere Europeenne filed Critical Cie Laitiere Europeenne
Application granted granted Critical
Publication of ATE531426T1 publication Critical patent/ATE531426T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polyamides (AREA)
AT07731348T 2006-04-27 2007-04-24 Verwendung von alpha-lactalbumin zur regulierung von glykämie ATE531426T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0603810A FR2900342B1 (fr) 2006-04-27 2006-04-27 Utilisation de l'alpha-lactalbumine pour la regulation de la glycemie
PCT/FR2007/000689 WO2007128901A1 (fr) 2006-04-27 2007-04-24 Utilisation de l'alpha-lactalbumine pour la regulation de la glycemie

Publications (1)

Publication Number Publication Date
ATE531426T1 true ATE531426T1 (de) 2011-11-15

Family

ID=37478857

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07731348T ATE531426T1 (de) 2006-04-27 2007-04-24 Verwendung von alpha-lactalbumin zur regulierung von glykämie

Country Status (10)

Country Link
US (1) US8648039B2 (de)
EP (1) EP2029231B1 (de)
AT (1) ATE531426T1 (de)
AU (1) AU2007247025B2 (de)
CA (1) CA2650495C (de)
DK (1) DK2029231T3 (de)
ES (1) ES2377015T3 (de)
FR (1) FR2900342B1 (de)
PL (1) PL2029231T3 (de)
WO (1) WO2007128901A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2318021A4 (de) * 2008-06-26 2012-10-31 Healthlinx Ltd Protokolle zur behandlung und prävention von fettsucht und daraus entstehenden komplikationen
GB0905555D0 (en) * 2009-03-31 2009-05-13 Peptcell Ltd Pharmaceutical agent
WO2010119088A2 (en) * 2009-04-15 2010-10-21 Bodo Melnik Milk and milk-based products modified to exhibit a reduced insulinemic index and/or reduced mitogenic activity
JP6842308B2 (ja) * 2017-01-31 2021-03-17 花王株式会社 夜間食後血糖上昇抑制剤
CN113827707B (zh) * 2021-09-30 2023-12-05 北京大学 a-乳白蛋白在抑制冠状病毒中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3343141A1 (de) * 1983-11-29 1985-06-05 Hermann P.T. 7400 Tübingen Ammon Verwendung von cystein-derivaten oder deren salzen, zur steigerung der insulinsekretion der langerhans'schen inseln der bauchspeicheldruese
DK0604684T3 (da) * 1992-12-23 1998-01-26 Campina Melkunie Bv Fremgangsmåde til genvinding af alphalactalbumin og betalactoglobulin fra et mælkeproteinprodukt
CN1092938C (zh) * 1996-04-12 2002-10-23 贝斯以色列护理医疗中心有限公司 用于糖尿病患者的补充食品条
EP1228707A1 (de) * 2001-02-01 2002-08-07 Campina Melkunie B.V. Verwendung von alpha-lactalbumin als praebiotischer Wirkstoff
US20020147153A1 (en) * 2001-02-14 2002-10-10 Functional Foods, Inc. Nutritional supplement to alleviate symptoms associated with reduced levels of serotonin
FR2875680B1 (fr) * 2004-09-29 2010-08-20 Veronique Marie-Pierre Peyrusson Compose dietetique pour combattre le syndrome metabolique

Also Published As

Publication number Publication date
DK2029231T3 (da) 2012-02-27
WO2007128901A1 (fr) 2007-11-15
CA2650495A1 (fr) 2007-11-15
PL2029231T3 (pl) 2012-05-31
FR2900342A1 (fr) 2007-11-02
ES2377015T3 (es) 2012-03-21
FR2900342B1 (fr) 2010-08-20
EP2029231A1 (de) 2009-03-04
CA2650495C (fr) 2016-01-05
AU2007247025B2 (en) 2013-01-10
EP2029231B1 (de) 2011-11-02
US8648039B2 (en) 2014-02-11
AU2007247025A1 (en) 2007-11-15
US20090325872A1 (en) 2009-12-31

Similar Documents

Publication Publication Date Title
Rees et al. Oxidative damage to extracellular matrix and its role in human pathologies
WO2010049678A3 (en) Treatment of energy utilization diseases
WO2006044531A3 (en) Antisense modulation of ptp1b expression
MX2009011359A (es) Derivados de pirimidinona y sus metodos de uso.
EA200900626A1 (ru) Комбинированное лечение ингибиторами sglt-2 (натрийзависимый сопереносчик глюкозы 2) и содержащими их фармацевтическими композициями
EP2217596B8 (de) Bicyclische heterocyclische derivate und ihre verwendung als modulatoren der aktivität von gpr 119
BRPI0909035A2 (pt) Uma composição cimentosa auto-niveladora com taxa controlada de desenvolvimento de resistência e resistência compressiva ultra- elevada no endurecimento e artigos produzidos a partir da mesma.
EP2361618A3 (de) Zusammensetzungen zur behandlung oder verhinderung von adipositas und insulin-resistenten erkrankungen
BRPI0918139A2 (pt) composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso
IL210778A0 (en) Pyrazolo [3,4]pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity
ATE531426T1 (de) Verwendung von alpha-lactalbumin zur regulierung von glykämie
DE602007001969D1 (de) Abgepacktes Konzentrat zur Zubereitung von Bouillon, Suppe, Sauce, Tunke oder zur Verwendung als Würze sowie das Konzentrat mit Konjac-Mannan
MX2009000834A (es) Composicion que tiene el efecto de tratar, prevenir o mejorar la diabetes o las complicaciones de la diabetes y bebida que comprende la misma.
BRPI0814931A2 (pt) Composto com atividade contra hcv, sua composição e seu uso
DE602008001092D1 (de) Abgepacktes konzentrat zur zubereitung von bouillon, suppe, sauce, tunke oder zur verwendung als würze sowie das konzentrat mit xanthan und tarakernmehl
BR112015013046A2 (pt) composição comestível, método de redução da amplitude do pico de glicose pós-prandial no sangue ou resposta glicêmica em uma pessoa diabética ou não diabética, método para tratar uma pessoa em necessidade deste para diabetes tipo 2 e uso de uma composição
WO2005113016A3 (en) Modulation of glucose-6-phosphatase translocase expression
WO2010119346A3 (en) Herbal compositions and methods for enhancing vital energy and athletic performance
ATE504595T1 (de) Il-22 zur behandlung von fettleibigkeit, diabetes,hyperlipidämie, hyperglykämie und insulinresistenz
DE602007012299D1 (de) Pyridinderivate für die behandlung von stoffwechselstörungen, die mit insulinresistenz oder hyperglykämie in zusammenhang stehen
BR112013030171A2 (pt) composição comestível, método para reduzir a amplitude de pico de glicose pós-prandial no sangue ou resposta glicêmica em uma pessoa não diabética, método para tratar uma pessoa com necessidade de tratamento para diabetes do tipo 2 e uso da composição
WO2009143065A3 (en) Rice bran extracts and methods of use thereof
TW200740451A (en) An agent for rising concentration of Adiponectin
BRPI0910559A2 (pt) associação da dronedarona com pelo menos um diurético, e sua aplicação em terapêutica.
WO2007072018A3 (en) Redox mediators